Rite Zone (RITEZONE)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Market cap of ₹8 Cr is very small relative to quarterly sales of ₹12 Cr, implying a low price-to-sales ratio if sales can stabilise.
• Promoter holding of 41.89% provides some alignment with minority shareholders.
• P/E of 17.48 is not optically expensive, though it is based on sharply depressed earnings.
• Share price is down significantly from the 52-week high of ₹36.55, reflecting de-rating.

Concerns

• Sales growth is negative at -17.60%, and profit has collapsed by -70.97%.
• Latest quarter net profit is effectively zero, indicating current operations are barely covering costs.
• Piotroski F-Score of 3/9 signals weak financial health and poor operating fundamentals.
• ROCE is only 7.73%, no dividend is paid, and book value/debt data are missing, limiting the ability to assess value.

AI Analysis

Let's start with what the numbers tell me. Rite Zone is a ₹8 crore market cap specialty chemical company trading at ₹20.25. At a P/E of 17.48, it doesn't look obviously cheap—and those earnings are shrinking fast: sales are down 17.60%, profit down 70.97%. The latest quarter shows ₹12 crore in sales and essentially zero net profit. That's not a business with a moat; that's a business under pressure. Graham would ask for margin of safety. I don't see it. ROCE of only 7.73% barely clears what a fixed deposit might give, and with zero dividend, the investor's only hope is price appreciation. A Piotroski F-Score of 3/9 reinforces my concern about financial health. Worse, I have no book value or debt-to-equity data—so I am flying blind on the balance sheet. Promoter holding of 41.89% is a small positive, but alignment alone doesn't protect me if operations keep deteriorating. The share has fallen from ₹36.55 to ₹20.25, but a falling price doesn't automatically mean value. In my experience, when a small chemical company is losing sales momentum, reporting zero quarterly profit, and generating poor returns on capital, the prudent move is to wait. This may eventually become a turnaround situation, but nothing in the figures says the turnaround has begun. I'd rather miss an uncertain opportunity than risk permanent capital. I need proof of stabilisation, real profits, and better capital efficiency before I put money to work here.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer